<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36414305</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>22</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Physical therapy for the management of motor symptoms in amyotrophic lateral sclerosis: protocol for a systematic review.</ArticleTitle><Pagination><StartPage>e063689</StartPage><MedlinePgn>e063689</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e063689</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-063689</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The prescription of an intervention plan can be challenging for the physical therapist, considering clinical phenotypes, individual prognosis and the rapid, progressive and deteriorating nature of amyotrophic lateral sclerosis (ALS). In this context, therapeutic exercises (eg, resistance and aerobic exercises) for patients with ALS remain controversial and may influence the treatment plan. Therefore, this review aims to critically assess whether physical therapy interventions are effective for improving functional capacity, quality of life and fatigue of individuals with ALS.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">Studies will be selected according to eligibility criteria, and language, geographical area or publication date will not be restricted. Four databases will be used: MEDLINE, EMBASE, Cochrane Library (CENTRAL) and Physiotherapy Evidence Database (PEDro). Searches will also be conducted on ClinicalTrials.gov and references from included studies. We plan to conduct the searches between October and December 2022. Two independent authors will examine titles and abstracts and exclude irrelevant studies and duplicates. We will assess the quality of studies and quality of evidence, and disagreements will be resolved with a third researcher. The findings will be presented in the text and tables; if possible, we will perform meta-analyses.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">No ethical approval is required because this study does not involve human beings. We will publish our findings in peer-reviewed journals.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER">CRD42021251350.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Stephano Tomaz</ForeName><Initials>ST</Initials><Identifier Source="ORCID">0000-0002-4537-516X</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil stephano.tomaz@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Aline Alves de</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-4424-3034</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pondofe</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melo</LastName><ForeName>Luciana Prot&#xe1;sio de</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resqueti</LastName><ForeName>Vanessa R</ForeName><Initials>VR</Initials><Identifier Source="ORCID">0000-0003-4817-9364</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentim</LastName><ForeName>Ricardo Alexsandro de Medeiros</ForeName><Initials>RAM</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health and Department of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Tatiana Souza</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-9611-1076</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026741" MajorTopicYN="Y">Physical Therapy Modalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Neurology</Keyword><Keyword MajorTopicYN="N">Neuromuscular disease</Keyword><Keyword MajorTopicYN="N">REHABILITATION MEDICINE</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36414305</ArticleId><ArticleId IdType="pmc">PMC9684999</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-063689</ArticleId><ArticleId IdType="pii">bmjopen-2022-063689</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Francis K, Bach JR, DeLisa JA. Evaluation and rehabilitation of patients with adult motor neuron disease. Arch Phys Med Rehabil 1999;80:951&#x2013;63. 10.1016/S0003-9993(99)90089-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-9993(99)90089-8</ArticleId><ArticleId IdType="pubmed">10453774</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin C, Unterborn JN, Ambrosio Carolyn D', et al. . Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29:5&#x2013;27. 10.1002/mus.10487</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10487</ArticleId><ArticleId IdType="pubmed">14694494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui AJ, Byl NN. A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis. J Neurol Phys Ther 2009;33:68&#x2013;87. 10.1097/NPT.0b013e31819912d0</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NPT.0b013e31819912d0</ArticleId><ArticleId IdType="pubmed">19556916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688&#x2013;700. 10.1056/NEJM200105313442207</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, et al. . Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol 2016;15:1182&#x2013;94. 10.1016/S1474-4422(16)30199-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30199-5</ArticleId><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:162&#x2013;72. 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 2019;32:771&#x2013;6. 10.1097/WCO.0000000000000730</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Majmudar S, Wu J, Paganoni S. Rehabilitation in amyotrophic lateral sclerosis: why it matters. Muscle Nerve 2014;50:4&#x2013;13. 10.1002/mus.24202</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24202</ArticleId><ArticleId IdType="pmc">PMC4433000</ArticleId><ArticleId IdType="pubmed">24510737</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons C, Pagnini F, Friede T, et al. . Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2018;1:CD011005. 10.1002/14651858.CD011005.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011005.pub2</ArticleId><ArticleId IdType="pmc">PMC6494184</ArticleId><ArticleId IdType="pubmed">29293261</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Shen D, Gao Y, et al. . A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed? Transl Neurodegener 2021;10:29. 10.1186/s40035-021-00250-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00250-5</ArticleId><ArticleId IdType="pmc">PMC8353789</ArticleId><ArticleId IdType="pubmed">34372914</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, et al. . Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2009;73:1218&#x2013;26. 10.1212/WNL.0b013e3181bc0141</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc0141</ArticleId><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Mitchell JD, Moore DH, et al. . Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012;330:CD001447. 10.1002/14651858.CD001447.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Haas VD. Physical therapy for individuals with amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis 2018;8:45&#x2013;54. 10.2147/DNND.S146949</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DNND.S146949</ArticleId><ArticleId IdType="pmc">PMC6065609</ArticleId><ArticleId IdType="pubmed">30890895</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Haas D, Krivickas L. Amyotrophic lateral sclerosis. In: Durstine JL, Moore GE, Painter PL, eds. ACSM&#x2019;s Exercise Management for Persons with Chronic Diseases and Disabilities. 3rd ed. Champaign, IL: Human Kinetics, 2008: 336&#x2013;41.</Citation></Reference><Reference><Citation>Bello-Haas VD. A framework for rehabilitation in degenerative diseases: planning care and maximizing quality of life. Neurol Report 2002;26:115&#x2013;29.</Citation></Reference><Reference><Citation>Paganoni S, Karam C, Joyce N, et al. . Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation 2015;37:53&#x2013;68. 10.3233/NRE-151240</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-151240</ArticleId><ArticleId IdType="pmc">PMC5223769</ArticleId><ArticleId IdType="pubmed">26409693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalron A, Mahameed I, Weiss I, et al. . Effects of a 12-week combined aerobic and strength training program in ambulatory patients with amyotrophic lateral sclerosis: a randomized controlled trial. J Neurol 2021;268:1857&#x2013;66. 10.1007/s00415-020-10354-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10354-z</ArticleId><ArticleId IdType="pubmed">33388929</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Li X, Li C, et al. . Effects of exercise in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Am J Phys Med Rehabil 2020;99:801&#x2013;10. 10.1097/PHM.0000000000001419</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001419</ArticleId><ArticleId IdType="pubmed">32452880</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1. 10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169:13&#x2013;21. 10.1016/S0022-510X(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazier JE, Harper R, Jones NM, et al. . Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160&#x2013;4. 10.1136/bmj.305.6846.160</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.305.6846.160</ArticleId><ArticleId IdType="pmc">PMC1883187</ArticleId><ArticleId IdType="pubmed">1285753</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C, Levvy G, Fitzpatrick R, et al. . The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients. J Neurol Sci 2000;180:94&#x2013;100. 10.1016/S0022-510X(00)00420-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00420-2</ArticleId><ArticleId IdType="pubmed">11090872</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons Z, Felgoise SH, Bremer BA, et al. . The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology 2006;67:1659&#x2013;64. 10.1212/01.wnl.0000242887.79115.19</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000242887.79115.19</ArticleId><ArticleId IdType="pubmed">17101900</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SR, Mount BM, Strobel MG, et al. . The McGill quality of life questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 1995;9:207&#x2013;19. 10.1177/026921639500900306</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/026921639500900306</ArticleId><ArticleId IdType="pubmed">7582177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kos D, Kerckhofs E, Nagels G, et al. . Assessing fatigue in multiple sclerosis: Dutch modified fatigue impact scale. Acta Neurol Belg 2003;103:185&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">15008502</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerdal A, Wahl A, Rust&#xf8;en T, et al. . Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health 2005;33:123&#x2013;30. 10.1080/14034940410028406</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14034940410028406</ArticleId><ArticleId IdType="pubmed">15823973</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons CJ, Mills RJ, Thornton EW, et al. . Development of a patient reported outcome measure for fatigue in motor neurone disease: the neurological fatigue index (NFI-MND). Health Qual Life Outcomes 2011;9:101. 10.1186/1477-7525-9-101</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-9-101</ArticleId><ArticleId IdType="pmc">PMC3282643</ArticleId><ArticleId IdType="pubmed">22107756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, et al. . Rayyan-a web and mobile APP for systematic reviews. Syst Rev 2016;5:210. 10.1186/s13643-016-0384-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhagen AP, de Vet HC, de Bie RA, et al. . The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235&#x2013;41. 10.1016/s0895-4356(98)00131-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0895-4356(98)00131-0</ArticleId><ArticleId IdType="pubmed">10086815</ArticleId></ArticleIdList></Reference><Reference><Citation>The Nordic Cochrane Centre, The Cochrane Collaboration . Review Manager 2014 [Computer program]. In: Review manager (RevMan). version 5.3. Copenhagen. The Nordic Cochrane Centre, 2012.</Citation></Reference><Reference><Citation>Armijo-Olivo S, da Costa BR, Cummings GG, et al. . PEDro or Cochrane to assess the quality of clinical trials? A Meta-Epidemiological study. PLoS One 2015;10:e0132634. 10.1371/journal.pone.0132634</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132634</ArticleId><ArticleId IdType="pmc">PMC4498768</ArticleId><ArticleId IdType="pubmed">26161653</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins D, Best D, Briss PA, et al. . Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490. 10.1136/bmj.328.7454.1490</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.328.7454.1490</ArticleId><ArticleId IdType="pmc">PMC428525</ArticleId><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinaki M, Mulder DW. Rehabilitation techniques for patients with amyotrophic lateral sclerosis. Mayo Clin Proc 1978;53:173&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">628227</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>